← Leaderboards
Soumitesh Chakravorty
University Of California, San Francisco
$1,066,801
Attributed
$2,133,601
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $730.4K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,133,601 · 1
By mechanism
R01$2,133,601 · 1
Top collaborators
- John Zapata Metcalfe3 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Adithya Cattamanchi$24,815,234
- Payam Nahid$19,473,523
- John Zapata Metcalfe$8,956,853
- Claudia Maria Denkinger$8,036,745
- Radojka Savic$8,230,011
Others in their field
Other Rising Stars on “Antimicrobial Resistance”
- Andrew Tomaras · Forge Therapeutics, Inc.$6,265,409
- Rangarajan Sampath · Siemens Healthcare Diagnostics Inc.$5,422,657
- Urs Oschner · Crestone, Inc.$4,595,632
- Ralf Lenigk · Ge Medical Systems Information Technologies, Inc$4,211,973
- Laurene Wang · Aimmax Therapeutics, Inc.$3,663,308
- Gary Nabors · Appili Therapeutics Usa Inc.$3,605,418
Research focus
Antimicrobial ResistanceBar CodesBiobankBiological ContainmentCalibrationCapitalCause Of DeathCellsCharacteristicsClinical ApplicationClinical AssessmentsClinical ManagementClinical TrialsComplexContainmentCostCountryCytolysisDecentralizationDetectionDiagnosticDrug RepurposingDrug Resistance In TuberculosisAcceleration
Grant awards (3)
A novel cartridge-based sequencing solution for decentralized M. tuberculosis resistance detection$700,104
R01 · FY2025 · AI
A novel cartridge-based sequencing solution for decentralized M. tuberculosis resistance detection$703,128
R01 · FY2024 · AI
A novel cartridge-based sequencing solution for decentralized M. tuberculosis resistance detection$730,369
R01 · FY2023 · AI